Latest Biosimilar Stories
A Substantial Need Remains for Emerging SLE Biologics That Can Prevent Acute Flares and That Treat Severe Manifestations, According to Findings from Decision Resources Group BURLINGTON, Mass.,
CRANBURY, N.J., Oct.
Physicians Indicate that Switching of Currently Treated Patients to Biosimilar Infliximab Is Likely to be Limited, According to Findings from Decision Resources Group BURLINGTON, Mass., Oct.
- BIO Investor Forum to be held October 7-8 in San Francisco - SAN DIEGO, Oct. 1, 2014 /PRNewswire/ -- Pfenex Inc.
Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced a full agenda
South Korea emerges among the frontrunners in the race to lead the global biosimilars market PHILADEPHIA, Sept.
- a meat pie that is usually eaten at Christmas in Quebec